Prosus Invests $460 million in French health tech Alan
Dutch investment company Prosus has invested $460 million into French health tech company Alan, valuing the startup at $6.3 billion, the company said on Wednesday.
Alan operates in France, Canada, Belgium and Spain and offers services such as health insurance and telehealth. The company has an annual recurring revenue of 800 million euros ($909.04 million) as of the first quarter of 2026.
* The investment will consist of both primary and secondary equity
